event thumb

About Event

This two-day conference focuses on translational aspects of substance use research among chemists, biologists, and behavioral scientists. The diversity of participants and attendees at this meeting (undergraduate students to senior faculty, chemists to psychiatrists) provides a unique venue for networking among different disciplines and in so doing promotes new and innovative approaches to medications development in addictions biology. The meeting provides a stimulating environment for young scientists who are strongly encouraged to present their work and interact with senior scientists. The BBC meeting has served as a “launch pad” for many young, innovative investigators to join the ever-growing world of SUD research.


Abstract Submission Information


Abstracts must describe the results of original, unpublished research that involves collecting and analyzing data. Abstracts must include the following: rationale, hypothesis, species, number of subjects, procedures (methods and statistical analyses), results, and conclusions (importance of findings). Abstracts are submitted with the travel award application, or at the time of registration.

Abstract Deadline: 24 February 2023
Download Abstract Submission Form

Registration Fees

$150 | Presenting Students and Postdocs (waived for travel awardees)
$250 | Non-Presenting Students
$375 | All others (including non-presenting postdocs)
$25 | Abstract Fee

Event Speakers


Madhukar Trivedi, MD

University of Texas Southwestern Medical Center

Advances and future directions in treatments for depression and substance use disorders


Carrie Jones, PhD

Chief, Molecular Neuropsychiatry Research Branch, Vanderbilt University

Modeling methamphetamine addiction in rodents: epigenetic consequences

Lunch & Learn!


Yu (Woody) Lin, MD, PhD

Division of Neuroscience and Behavior, NIDA

Strategies to succeed research career transition and independence

Plenary Symposium


Paule Joseph, PhD

National Institute of Alcohol Abuse and Alcoholism, NIH

Inflammatory markers of substance use and mood disorders


Irma (Lisa) Cisneros, PhD

University of Texas Medical Branch

Danger-associated molecular patterns (DAMPS) and mitochondrial antiviral protein (MAVS) trigger neuroinflammatory networks in substance use disorder


Saadet Inan, MD, PhD

Temple University

Chemokine and cytokine receptor antagonists as potential therapeutics for psychostimulant use disorder


Marisa Roberto, PhD

Scripps Research Institute

Neuroimmune systems as therapeutic targets for mental health and substance use disorders